aTyr Pharma's market cap is currently $70.38M. The company's EPS TTM is €-0.18759182419999998; its P/E ratio is ―; aTyr Pharma is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is €-0.16. See an overview of income statement, balance sheet, and cash flow financials.
